Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
Clinical Kidney Journal|May 12, 2025
Malignancies and glomerulonephritis: when to suspect and when to screen?Ahmet Murt, Ilay Berke, Annette Bruchfeld, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 1, 2019
Children of a lesser god: exclusion of chronic kidney disease patients from clinical trialsCarmine Zoccali, Peter J Blankestijn, Annette Bruchfeld, et al.
Clinical Kidney Journal|December 4, 2023
Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patientsGaye Hafez, Jolanta Malyszko, Aleksandra Golenia, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 9, 2025
Disease-modifying anti-nephropathic drugs (DMANDs)-a definition proposed by the Immunonephrology Working Group (IWG) of the European Renal Association (ERA)Y K Onno Teng, Eleni Frangou, Andreas Kronbichler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 10, 2021
The management of lupus nephritis as proposed by EULAR/ERA 2019 versus KDIGO 2021Hans-Joachim Anders, Jerome Loutan, Annette Bruchfeld, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 31, 2026
Extrarenal Disease in ANCA-Associated Vasculitis: Challenges and Evolving Therapeutic Strategies on behalf of the Immunonephrology Working Group (IWG) of the ERAAglaia Chalkia, Eleni Frangou, Annette Bruchfeld, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 24, 2015
Outcome and treatment of elderly patients with ANCA-associated vasculitisMaria Weiner, Su Mein Goh, Aladdin J Mohammad, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 7, 2004
The influence of hepatitis C and iron replacement therapy on plasma pentosidine levels in haemodialysis patientsMarcelo M Nascimento, Mohamed E Suliman, Annette Bruchfeld, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 8, 2021
The management of membranous nephropathy-an updateFernando Caravaca-Fontán, Gema M Fernández-Juárez, Jürgen Floege, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 7, 2023
Prophylactic and early outpatient treatment of COVID-19 in patients with kidney disease: considerations from the Immunonephrology Working Group of the European Renal Association (ERA-IWG)Marc Hilhorst, Frederike J Bemelman, Annette Bruchfeld, et al.
Pageof 14